High Expression Level of MMP7 and Mir-489-3p/MMP7 Axis Associates with Venetoclax Resistance in Acute Myelogenous Leukemia

作者
Li Wang,Jishi Wang
出处
期刊:Blood [Elsevier BV]
卷期号:142 (Supplement 1): 5768-5768 被引量:1
标识
DOI:10.1182/blood-2023-186242
摘要

The BCL2 inhibitor venetoclax used to treat acute myelogenous leukemia (AML). Although this has been a promising therapeutic option for patients with AML, many of these patients develop resistance and relapsed disease. Matrix metalloproteinases (MMPs) were demonstrated to have important implications in the progression and invasiveness of many malignant disorders. In contrast, the biological significance of these molecules in AML is not clear. We determined the levels of MMP-7 in the bone marrow of 76 patients with AML. 70 bone marrow donors served as normal controls. The level of MMP-7 was significantly higher in the AML than in the normal controls. MMP-7 levels were significantly lower in the AML patients who achieved a complete remission (CR) than in those who did not. Through in vitro studies, we observed that MMP7 levels were elevated in AML cell lines (U937, THP-1) and in Venetoclax-resistant AML cell lines (U937R, THP-1R) and that downregulation of MMP7 could enhance Venetoclax efficacy in U937R and THP-1R cells. Our in vitro and in vivo investigations show that miR-489-3p was downregulated in Venetoclax-resistant AML cell lines and promoting level of miR-489-3p expression can directly suppressing MMP-7 expression. Pharmacological inhibition of miR-489-3p markedly reversed the effects of Venetoclax-resistant upon AML proliferation and metastasis. Thus, our study suggests that MMP-7 is an essential factor in AML, and regulator the miR-489-3p/MMP7 axis may be a novel treatment strategy for overcoming Venetoclax resistance in AML.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
尼古丁真完成签到,获得积分10
刚刚
恢恢完成签到,获得积分20
1秒前
Clara完成签到 ,获得积分10
2秒前
满意如冬发布了新的文献求助10
2秒前
周程朋完成签到,获得积分10
2秒前
2秒前
3秒前
小后院完成签到,获得积分10
3秒前
ye完成签到 ,获得积分10
3秒前
3秒前
小二郎的应助被ranrika采纳,获得10
3秒前
流云完成签到,获得积分10
4秒前
4秒前
平凡完成签到,获得积分0
5秒前
云彦完成签到,获得积分10
5秒前
6秒前
徐XU发布了新的文献求助10
7秒前
7秒前
Zz发布了新的文献求助10
8秒前
orixero的应助被lilili采纳,获得10
9秒前
9秒前
Drtaoao完成签到 ,获得积分10
11秒前
ahsh发布了新的文献求助10
12秒前
12秒前
12秒前
12秒前
祈愿a完成签到,获得积分10
13秒前
Lucas的应助被王肄博采纳,获得10
13秒前
14秒前
ddd发布了新的文献求助10
14秒前
14秒前
洁净的语山完成签到 ,获得积分10
15秒前
科研通AI6.3的应助被满意如冬采纳,获得10
17秒前
ranrika发布了新的文献求助10
17秒前
sheishei完成签到,获得积分10
17秒前
17秒前
18秒前
开心完成签到,获得积分10
18秒前
大个的应助被郭娅楠采纳,获得10
18秒前
硕果累累完成签到 ,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186676
求助须知:如何正确求助?哪些是违规求助? 9574945
关于积分的说明 21839037
捐赠科研通 7784275
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559187
邀请新用户注册赠送积分活动 2481611